Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.
21 U.S.C. 356b Reports of postmarketing studies
21 U.S.C. 356b Reports of postmarketing studies, “Reports of postmarketing studies”, is a U.S. Code section of Part A—Drugs and Devices; in force.
https://ontology.bommaritollc.com/id/01a0f06c-ccea-769f-b60a-251047e97ffa
Elsewhere
Facts
| adms:identifier | |
| eli:cites | |
| prov:wasDerivedFrom | |
| schema:isPartOf | |
| schema:legislationIdentifier | 21 U.S.C. 356b |
| schema:legislationJurisdiction | |
| schema:legislationLegalForce | |
| schema:legislationType | |
| schema:name | Reports of postmarketing studiesen |
| schema:url | |
| skos:prefLabel | 21 U.S.C. 356b Reports of postmarketing studiesen |
Related
Rules made under it (4)eli:based_on
- 21 CFR Part 230—Certification and postmarketing reporting for designated medical gases (Eff. 12-18-25)
- 21 CFR Part 314—Applications for FDA approval to market a new drug
- 21 CFR Part 601—Licensing
- 21 CFR Part 740—Cosmetic product warning statements